Fluticasone Furoate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fluticasone Furoate
US Exclusivities

PharmaCompass Sponsored Ads

Contact Supplier

Vamsi Labs Fluticasone Furoate

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Fluticasone Furoate

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Fluticasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 12 USDMF, 4 CEP/COS, 2 JDMF, 3 EU WC, 1 KDMF, 20 NDC API, 20 Listed Suppliers, $ API Reference Price

26 API Suppliers
12 USDMF
4 CEP/COS
2 JDMF
3 EU WC
1 KDMF
20 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

108 FDF Dossiers, 9 FDA Orange Book, 80 Europe, 7 Canada, 4 Australia, 5 South Africa, 3 Listed Dossiers

108 FDF Dossiers
9 FDA Orange Book
80 Europe
7 Canada
4 Australia
5 South Africa
3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.2MG/INH, SPRAY, METERED;NASAL - 0.0275MG/SPRAY

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH
POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH
POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH
POWDER;INHALATION - 0.05MG/INH
POWDER;INHALATION - 0.1MG/INH
POWDER;INHALATION - 0.2MG/INH
SPRAY, METERED;NASAL - 0.0275MG/SPRAY

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 1 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 4 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 17 Kerry, 1 Kima Chemical, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 1 The Dow Chemical Company, 2 Vasa Pharmachem

1 Rochem International Inc
1 SPI Pharma
1 DKSH
2 Faran Shimi Pharmaceutical
3 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
4 Actylis
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
4 DFE Pharma
1 Finar
6 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
17 Kerry
1 Kima Chemical
12 Microlex e.U
1 Nanjing Bold Chemical
1 Pharmatrans-Sanaq
2 Pluviaendo
2 Prachin Chemical
7 Roquette
6 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
1 The Dow Chemical Company
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 16 Thickeners and Stabilizers, 15 Solubilizers, 12 Direct Compression, 9 Lubricants & Glidants, 8 Co-Processed Excipients, 8 Granulation, 7 Parenteral, 5 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 4 Emulsifying Agents, 4 Coating Systems & Additives, 4 Film Formers & Plasticizers, 3 Topical, 3 Controlled & Modified Release, 2 Surfactant & Foaming Agents, 2 Chewable & Orodispersible Aids, 2 Taste Masking, 1 API Stability Enhancers

37 Fillers, Diluents & Binders
16 Thickeners and Stabilizers
15 Solubilizers
12 Direct Compression
9 Lubricants & Glidants
8 Co-Processed Excipients
8 Granulation
7 Parenteral
5 Rheology Modifiers
5 Disintegrants & Superdisintegrants
4 Emulsifying Agents
4 Coating Systems & Additives
4 Film Formers & Plasticizers
3 Topical
3 Controlled & Modified Release
2 Surfactant & Foaming Agents
2 Chewable & Orodispersible Aids
2 Taste Masking
1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 53 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
53 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 73 Finished Drug Prices, 35 Annual Reports

2 US Medicaid Prescriptions
73 Finished Drug Prices
35 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

111 US Patents, 5 US Exclusivities, 5 Health Canada Patents

111 US Patents
5 US Exclusivities
5 Health Canada Patents

$ API Ref.Price (USD/KG) : 41,762 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

5 All

01 4GLAXO GRP LTD

02 1GLAXOSMITHKLINE

filter Product Reset all filters

5 All

01 1FLUTICASONE FUROATE

02 4FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

filter Exclusivity Expiration Date Reset all filters

5 All

01 12026-03-01

02 22026-05-13

03 22026-11-13

filter Exclusivity Code Reset all filters

5 All

01 1M-290

02 1NPP

03 1NS

04 2PED

EUROAPI Fluticasone

Product Main Page

GLAXO GRP LTD

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NS

Exclusivity Expiration Date

2026-05-13

Application Number

204275

Product Number

3

Exclusivity Details

01

GLAXO GRP LTD

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

PharmScience R&D

Not Confirmed

GLAXO GRP LTD

United Kingdom

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Exclusivity Code : NS

Exclusivity Expiration Date : 2026-05-13

Application Number : 204275

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GLAXO GRP LTD

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-13

Application Number

204275

Product Number

1

Exclusivity Details

02

GLAXO GRP LTD

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

PharmScience R&D

Not Confirmed

GLAXO GRP LTD

United Kingdom

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-13

Application Number : 204275

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GLAXO GRP LTD

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2026-11-13

Application Number

204275

Product Number

3

Exclusivity Details

03

GLAXO GRP LTD

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

PharmScience R&D

Not Confirmed

GLAXO GRP LTD

United Kingdom

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2026-11-13

Application Number : 204275

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GLAXO GRP LTD

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PED

Exclusivity Expiration Date

2026-11-13

Application Number

204275

Product Number

1

Exclusivity Details

04

GLAXO GRP LTD

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

PharmScience R&D

Not Confirmed

GLAXO GRP LTD

United Kingdom

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

Exclusivity Code : PED

Exclusivity Expiration Date : 2026-11-13

Application Number : 204275

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GLAXOSMITHKLINE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUTICASONE FUROATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-290

Exclusivity Expiration Date

2026-03-01

Application Number

205625

Product Number

3

Exclusivity Details

05

GLAXOSMITHKLINE

FLUTICASONE FUROATE

PharmScience R&D

Not Confirmed

GLAXOSMITHKLINE

United Kingdom

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUTICASONE FUROATE

Exclusivity Code : M-290

Exclusivity Expiration Date : 2026-03-01

Application Number : 205625

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!